Dechra Pharmaceuticals PLC
OTC: DCHPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Isidro A. Consunji
- Employees
- 2,457
- Headquarters
- Northwich, United Kingdom
- IPO year
- 2016
- Market cap
- $5.3B
- Website
- https://www.dechra.com
Loading DCHPF…
Loading profile data…Frequently asked questions about DCHPF
What does Dechra Pharmaceuticals PLC (DCHPF) do?
Dechra Pharmaceuticals PLC specializes in the entire lifecycle of veterinary products, from development and manufacturing to regulatory approval, marketing, and sales, primarily serving veterinarians. The company's operations are structured across three main divisions: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals...
Where does DCHPF trade?
Dechra Pharmaceuticals PLC (DCHPF) trades on the Other OTC.
What sector is DCHPF in?
Dechra Pharmaceuticals PLC (DCHPF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Dechra Pharmaceuticals PLC?
Isidro A. Consunji is the chief executive officer of Dechra Pharmaceuticals PLC (DCHPF).
Where is Dechra Pharmaceuticals PLC headquartered?
Dechra Pharmaceuticals PLC is headquartered in United Kingdom.
Does DCHPF pay a dividend?
Yes — Dechra Pharmaceuticals PLC (DCHPF) paid a trailing twelve-month dividend of USD 0.55 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did DCHPF go public?
Dechra Pharmaceuticals PLC (DCHPF) completed its initial public offering in 2016.